VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that it will be ...
The introduction of PET scans that can image more than one radiotracer simultaneously could revolutionize oncology by ...
The new brand name and visual identity has been designed with a clean and elegant look reflective of the Company’s vision for a streamlined approach to dedicated brain PET imaging, and the ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) announced that it will open its first US brain-dedicated positron emission tomography (PET) scanning clinic at the HCA Florida University Medical ...
The Centers for Medicare & Medicaid Services (CMS) has expanded coverage of brain amyloid positron-emission tomography (PET) imaging for the diagnosis of Alzheimer's disease (AD). The CMS decision, ...
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B ...
JOHNS CREEK — Officials at Emory John Creek Hospital are unveiling new equipment in the fight against cancer. They say the mobile position emission tomography (PET) scan unit is a highly-advanced form ...
FDA acceptance positions 18F-FET as a potential first-in-class US-approved amino acid PET agent for glioma characterization, addressing a major posttreatment imaging specificity gap.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results